Remove 2000 Remove Cannabinoids Remove Medical Evaluation Remove Patients
article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.).

Banking 45